The pharmaceutical giant Gilead Sciences Inc. just days ago accused the United States of violating collaboration agreements in a new civil court complaint in Washington that comes as the company is winning praise from the Trump administration for a drug that shows early promise for treating patients suffering from the novel coronavirus.

Gilead’s case in the U.S. Court of Federal Claims, filed by lawyers from Wilmer Cutler Pickering Hale and Dorr, confronts agreements between the United States and Gilead concerning HIV treatment and prevention. The complaint alleged the federal government had asserted “patents that it secretly obtained in violation of the collaboration agreements that Gilead entered into and executed in good faith.”